TREA

79094022 - REINNERVATE

Follow

Information

  • Trademark
  • 79094022
  • Serial Number
    79094022
  • Registration Number
    4100733
  • Filing Date
    September 07, 2010
    15 years ago
  • Registration Date
    February 21, 2012
    13 years ago
  • Transaction Date
    September 26, 2021
    4 years ago
  • Status Date
    September 07, 2020
    5 years ago
  • Published for Opposition Date
    December 06, 2011
    14 years ago
  • Location Date
    February 21, 2012
    13 years ago
  • Status Code
    404
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FARRELL, ANNE M
  • Attorney Docket Number
    6222RL-3
    Attorney Name
    Miriam D. Trudell
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
REINNERVATE
Case File Statements
  • CC0000: The color(s) blue, white and black is/are claimed as a feature of the mark.
  • D10000: "REINNERVATE"
  • DM0000: The mark consists of a circular device to the left in blue with white connected circles on it, and to the right in black is the wording "REINNERVATE".
  • GS0011: Biological preparations for use in the induction of cell differentiation in cell cultures and synthetic small molecules for use in the induction of in-vitro cell differentiation, other than medical; cell growth media for growing cells for use in scientific research; media for cell culture for use, namely, in non-medical research and biotechnological laboratories; chemical preparations for biotechnological purposes, namely, for the induction of cell differentiation, in particular stem cell differentiation; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations, agents and reagents for use in cellular research; biochemicals, namely, monoclonal antibodies other than for medical or veterinary purposes; biochemicals, namely, antibodies for diagnostic, laboratory, industrial or scientific use other than medical; biochemical products containing antibodies for use in scientific research
  • GS0051: Pharmaceutical preparations for the treatment of skin and neuro-degenerative diseases; medical biological reagents for use in molecular biology; medical diagnostic reagents; medical diagnostic reagents for in vitro laboratory tests; chemical reagents for medical and veterinary purposes; chemical preparations, agents and reagents for medical and veterinary use, namely, in the differentiation of cell types; biological preparations for the treatment of skin and neuro-degenerative diseases; cell growth media for growing cells for medical or clinical use; diagnostic agents, preparations and substances for medical purposes, namely, for use in binding or detecting antibodies, and in the development of antibodies
  • GS0091: Cell culture apparatus and instruments for laboratory or research medical use; laboratory apparatus, namely, cell culture vessels, multiwell plates, petri dishes, cell culture well inserts, cell factories, cell culture flasks and bioreactors for use in the separation of antibodies; reaction units, namely, cell based assays, routine cell cultures, cell passaging and perfusion cell culture systems containing chemical or biological reagents; cell culture scaffolds, namely, microspun fibres and microporous polystyrene substrates coated with extra-cellular matrices; deep well plates, namely, deep reservoir petri dishes with and without well insert cradles used in laboratory research
  • GS0401: Batch biological and chemical treatment services of materials; batch biological and chemical material treatment involving cell culture processes and the differentiation of cell types; treatment of human, animal and plant cells, bacteria and antibody materials by culturing such cells in three dimensions; material treatment involving three dimensional cell culture processes and in-vitro stem cell differentiation
  • GS0411: Education services, namely, provision of training, arranging and conducting of seminars and workshops all in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; on-line non-downloadable electronic publications, namely, bulletins and journal articles in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy
  • GS0421: Scientific research and design services in the field of three dimensional cell culture and analytical processes; industrial analysis and research services in the field of cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; laboratory services, namely, analysis and research in the field of cell and tissue cultures and their treatment; biotechnology research; laboratory services relating to the production of antibodies; growing cell cultures for research purposes; testing pharmaceutical, medical and biological agents for others; consultancy relating to biotechnology
Case File Event Statements
  • 9/25/2021 - 4 years ago
    32 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC
  • 9/25/2021 - 4 years ago
    31 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 11/30/2019 - 6 years ago
    30 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 6/22/2019 - 6 years ago
    29 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 6/22/2019 - 6 years ago
    28 - INVALIDATION PROCESSED Type: INPC
  • 5/28/2019 - 6 years ago
    27 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 9/28/2018 - 7 years ago
    26 - CANCELLED SECTION 71 Type: C71T
  • 9/29/2017 - 8 years ago
    25 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 2/21/2017 - 8 years ago
    24 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 9/22/2012 - 13 years ago
    23 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/5/2012 - 13 years ago
    22 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/4/2012 - 13 years ago
    21 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 5/21/2012 - 13 years ago
    20 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/21/2012 - 13 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/6/2011 - 14 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/6/2011 - 14 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/16/2011 - 14 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/28/2011 - 14 years ago
    15 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/28/2011 - 14 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 9/30/2011 - 14 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/22/2011 - 14 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/22/2011 - 14 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/22/2011 - 14 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/17/2011 - 14 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/30/2011 - 14 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/30/2011 - 14 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/30/2011 - 14 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/29/2011 - 14 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2011 - 14 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/22/2011 - 14 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/22/2011 - 14 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/17/2011 - 14 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR